{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T10:16:17Z","timestamp":1694859377151},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Romania","award":["615\/1\/17.01.2019"],"award-info":[{"award-number":["615\/1\/17.01.2019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Co-occurrence of cytogenetic and molecular abnormalities is frequently seen in patients with acute myeloid leukemia (AML). The clinical outcome and genetic abnormalities of AML may vary; therefore, genetic investigation must be complex, using several techniques, to have an appropriate characterization of the AML genome and its clinical impact. The available molecular markers can predict prognosis only partially. Acute promyelocytic leukemia subtype M3 <jats:bold>(<\/jats:bold>AML M3) is a subtype of AML characterized by the presence of promyelocytic leukemia-retinoic acid receptor alpha (<jats:italic toggle=\"yes\">PML-RARA<\/jats:italic>) genes fusion. Targeted treatment with all-trans-retinoic acid (ATRA) and ATRA combined with arsenic trioxide significantly improved the survival of AML M3 patients. Unknown prognostic factors could contribute to the early death of these patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient Concerns:<\/jats:title>\n            <jats:p>We present the case of a young female (20 years old) patient, who presented at the emergency department 5 months after giving birth to her first child, complaining of asthenia, fatigue, general musculoskeletal pain, and fever (38\u00b0C), symptoms having been present for the previous 6 days. The patient denied any chronic diseases in her medical and family history.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Laboratory analysis revealed severe pancytopenia. Cytogenetic and molecular analyzes revealed chromosomal abnormalities (trisomy 8), <jats:italic toggle=\"yes\">PML-RARA<\/jats:italic> gene fusion, and fms-like tyrosine kinase 3 <jats:italic toggle=\"yes\">(FLT3)<\/jats:italic> gene mutation. The immunophenotypic analysis was also suggestive for AML M3 according to the FAB classification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Specific treatment was initiated for AML M3 and for secondary conditions. Molecular and cytogenetic analyzes were performed to have a more detailed characterization of the patient's genome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcome:<\/jats:title>\n            <jats:p>Seventy-two hours after admission, she developed psychomotor agitation, confusion, coma, and convulsion. Subsequent deterioration and early death were caused by intracerebral hemorrhage with multiple localization and diffuse cerebral edema.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The presence of <jats:italic toggle=\"yes\">FLT3<\/jats:italic> internal tandem duplication (ITD) mutation may explain the rapid and progressive degradation of this AML M3 case and it may be used as a prognostic marker even when co-occuring with other markers such as <jats:italic toggle=\"yes\">PML-RARA<\/jats:italic> gene fusion and trisomy 8. We consider that <jats:italic toggle=\"yes\">FLT3<\/jats:italic> ITD mutation analysis in young patients with AML should be performed as soon as possible. New strategies for patients\u2019 education, AML (or cancers in general) prevention, and treatment are needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019730","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T08:44:34Z","timestamp":1585817074000},"page":"e19730","source":"Crossref","is-referenced-by-count":3,"title":["Co-occurrence of PML-RARA gene fusion, chromosome 8 trisomy, and FLT3 ITD mutation in a young female patient with de novo acute myeloid leukemia and early death"],"prefix":"10.1097","volume":"99","author":[{"given":"Florin","family":"Tripon","sequence":"first","affiliation":[{"name":"Department of Medical Genetics"},{"name":"Genetics Laboratory, Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rguMure\u015f"},{"name":"Genetics Laboratory, Mures County Emergency Clinical Hospital (SCJU T\u00e2rgu Mure\u015f)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Andrei","family":"Crauciuc","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics"},{"name":"Genetics Laboratory, Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rguMure\u015f"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Bogli\u015f","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics"},{"name":"Genetics Laboratory, Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rguMure\u015f"},{"name":"Genetics Laboratory, Mures County Emergency Clinical Hospital (SCJU T\u00e2rgu Mure\u015f)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriu","family":"Moldovan","sequence":"additional","affiliation":[{"name":"Genetics Laboratory, Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rguMure\u015f"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"S\u00e1ndor-K\u00e9ri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rguMure\u015f, T\u00e2rguMure\u015f"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n Jr","family":"Benedek","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rguMure\u015f, T\u00e2rguMure\u015f"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian Pavel","family":"Trifa","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Medicine and Pharmacy \u201cIuliu Ha\u0163ieganu\u201d, Cluj-Napoca, Romania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"B\u0103nescu","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics"},{"name":"Genetics Laboratory, Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rguMure\u015f"},{"name":"Genetics Laboratory, Mures County Emergency Clinical Hospital (SCJU T\u00e2rgu Mure\u015f)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,4]]},"reference":[{"key":"R1-20230915","first-page":"328","article-title":"Acute myeloid leukemia-genetic alterations and their clinical prognosis","volume":"11","author":"Lagunas-Rangel","year":"2017","journal-title":"Int J HematolOncol Stem Cell Res"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1038\/s41375-018-0257-z","article-title":"Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care","volume":"32","author":"D\u00f6hner","year":"2018","journal-title":"Leukemia"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"2536705","DOI":"10.1155\/2016\/2536705","article-title":"From six gene polymorphisms of the antioxidant system, only GPX Pro198Leu and GSTP1 Ile105Val modulate the risk of acute myeloid leukemia","volume":"2016","author":"B\u0103nescu","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12185-017-2340-z","article-title":"Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia","volume":"107","author":"Kuwatsuka","year":"2018","journal-title":"Int J Hematol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00277-016-2844-2","article-title":"MCM7 polymorphisms associated with the AML relapse and overall survival","volume":"96","author":"Lee","year":"2017","journal-title":"Ann Hematol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"e9657","DOI":"10.1097\/MD.0000000000009657","article-title":"Case report: purulent transformation of granulocytic sarcoma: an unusual pattern of differentiation in acute promyelocytic leukemia","volume":"97","author":"Collinge","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"e12214","DOI":"10.1097\/MD.0000000000012214","article-title":"Whole exome sequencing detects CHST3 mutation in patient with acute promyelocytic leukemia: a case report","volume":"97","author":"Feng","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R9-20230915","first-page":"245","article-title":"Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia\u2014case study","volume":"27","author":"Tripon","year":"2019","journal-title":"Rev Romana Med Lab"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"e15209","DOI":"10.1097\/MD.0000000000015209","article-title":"Cytogenetic and molecular characterization of an oligoasthenozoospermia male carrier of an unbalanced Y;22 translocation: a case report","volume":"98","author":"Jia","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R11-20230915","first-page":"471","article-title":"The utility of molecular genetic techniques in craniosynostosis cases associated with intellectual disability","volume":"26","author":"Bogli\u015f","year":"2018","journal-title":"Rev Romana Med Lab"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/leu.2015.177","article-title":"Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia","volume":"30","author":"Ruminy","year":"2016","journal-title":"Leukemia"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/labinvest.2017.124","article-title":"Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma","volume":"98","author":"Piton","year":"2018","journal-title":"Lab Invest"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3324\/haematol.11100","article-title":"Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup","volume":"92","author":"Schaich","year":"2007","journal-title":"Haematologica"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.18203\/2320-6012.ijrms20172464","article-title":"The possible significance of trisomy 8 in acute myeloid leukemia","volume":"5","author":"Vaniawala","year":"2017","journal-title":"Int J Res Med Sci"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/0971-6866.96673","article-title":"Trisomy 8 in leukemia: a GCRI experience","volume":"18","author":"Bakshi","year":"2012","journal-title":"Indian J Hum Genet"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/BIC.S19614","article-title":"Trisomy 8 acute myeloid leukemia analysis reveals new insights of DNA methylome with identification of HHEX as potential diagnostic marker","volume":"7","author":"Saied","year":"2015","journal-title":"Biomark Cancer"},{"issue":"(suppl 1)","key":"R18-20230915","first-page":"5101","article-title":"The clinical characteristics, genetic alterations and prognostic significance of acute myeloid leukemia (AML) with trisomy 8","volume":"130","author":"Gbadamosi","year":"2017","journal-title":"Blood"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11864-019-0612-y","article-title":"Prognostic significance of complex karyotypes in acute myeloid leukemia","volume":"20","author":"Daneshbod","year":"2019","journal-title":"Curr Treat Options Oncol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","article-title":"Targeting FLT3 mutations in AML: review of current knowledge and evidence","volume":"33","author":"Daver","year":"2019","journal-title":"Leukemia"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.1007\/s13277-016-4815-6","article-title":"Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population","volume":"37","author":"B\u0103nescu","year":"2016","journal-title":"Tumour Biol"},{"key":"R22-20230915","first-page":"87","article-title":"FLT-3 ITD positive acute basophilic leukemia with rare complex karyotype presenting with acute respiratory failure: case report","volume":"26","author":"Antohe","year":"2018","journal-title":"Rev Romana Med Lab"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.gene.2013.05.054","article-title":"XRCC3 Thr241Met polymorphism and risk of acute myeloid leukemia in a Romanian population","volume":"526","author":"B\u0103nescu","year":"2013","journal-title":"Gene"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1200\/jco.2010.28.15_suppl.6562","article-title":"The role of FLT3 in sole trisomy 8 acute myeloid leukemia","volume":"28","author":"Block","year":"2010","journal-title":"J Clin Oncol"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"e6641","DOI":"10.1097\/MD.0000000000006641","article-title":"Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: a nationwide, multicenter 10-year epidemiological study","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"e018523","DOI":"10.1136\/bmjopen-2017-018523","article-title":"Factors associated with insufficient awareness of breast cancer among women in Northern and Eastern China: a case-control study","volume":"8","author":"Liu","year":"2018","journal-title":"BMJ Open"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"e9324","DOI":"10.1097\/MD.0000000000009324","article-title":"Analysis of early death in newly diagnosed acute promyelocytic leukemia patients","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R29-20230915","first-page":"461","article-title":"Multiplex ligation dependent probe amplification\u2014a useful, fast and cost-effective method for identification of small supernumerary marker chromosome in children with developmental delay and congenital heart defect","volume":"26","author":"Crauciuc","year":"2018","journal-title":"Rev Romana Med Lab"},{"key":"R30-20230915","first-page":"9","article-title":"Do we really need genetic tests in current practice?","volume":"27","author":"B\u0103nescu","year":"2019","journal-title":"Rev Romana Med Lab"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.leukres.2017.05.022","article-title":"Aneuploidy identification in pre-B acute lymphoblastic leukemia patients at diagnosis by multiplex ligation-dependent probe amplification (MLPA)","volume":"59","author":"V\u00e1zquez-Reyes","year":"2017","journal-title":"Leuk Res"},{"key":"R32-20230915","first-page":"898","article-title":"Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification","volume":"129","author":"B\u0103nescu","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"R33-20230915","first-page":"239","article-title":"The value of FLT3, NPM1 and DNMT3A genes mutation analysis in acute myeloid leukemia diagnosis","volume":"27","author":"Banescu","year":"2019","journal-title":"Rev Romana Med Lab"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:14:40Z","timestamp":1694816080000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019730"}},"subtitle":["A CARE case report"],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":33,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019730","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}